Stacey Ruiz

Stacey Ruiz is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Vice President of Clinical Development at Renibus Therapeutics Inc since 2020. With experience as an Independent Consultant in Biotech Development and multiple leadership roles at Abcentra and CardioVax, Stacey has focused on drug development strategies within pre-clinical and clinical contexts, emphasizing peptide vaccines and monoclonal antibodies. Previously, at La Jolla Pharmaceutical Company, Stacey led business development efforts, while at Reata Pharmaceuticals, oversight of medical affairs and product development strategies was provided. Stacey began a career in research as a Post-doctoral Fellow at the Dana-Farber Cancer Institute after earning a PhD in Cancer Biology from UT/MD Anderson Cancer Center and holds a Bachelor’s degree in Science Preprofessional Studies from the University of Notre Dame.